SONJA JOHNSON: Open Payments
NPI 1053931048 · LANCASTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,459 in 169 payments from 14 companies in 2025. Trend: 2023 $123 · 2024 $149 · 2025 $2,459
Food & beverage: $2,459
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $583 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 40 | $415 |
| Otsuka America Pharmaceutical, Inc. | 16 | $274 |
| Axsome Therapeutics, Inc. | 17 | $262 |
| Alkermes, Inc. | 12 | $197 |
| Neurocrine BioSciences, Inc. | 8 | $171 |
| Supernus Pharmaceuticals, Inc. | 11 | $169 |
| Vanda Pharmaceuticals Inc. | 13 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Collegium Pharmaceutical, Inc. | 2 | $47 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Auvelity, ARISTADA, INGREZZA, Qelbree, FANAPT.
Industry payments across OH — which companies pay providers there.
